PharmaShots Interview: Janssen’s Dr. Allitia DiBernardo Shares Insights on the Availability of Ponvory in the US

In an interview with PharmaShots, Dr. Allitia DiBernardo, Global Head of Medical Affairs for Neurology at the Janssen share her views on the availability of Ponvory in the US for MS patients.Shots:Ponvory offers patients superior efficacy in reducing annualized relapses and brain lesions over established oral therapy teriflunomide (Aubagio), with a safe and generally well-tolerated profile…

BySenior EditorMay 24, 2021

VIEWPOINTS

PharmaShots Interview: Biogen’s Monica Mann Shares Insight on Plegridy to Treat Multiple Sclerosis

In an interview with PharmaShots, Monica Mann, Head of Global Medical, Multiple Sclerosis at Biogen shares her views on the Plegridy and how it works on MS patients. She also shed light on the approval of the therapy in the US and EU.Shots:The approval of Plegridy (IM) by the EC and the US FDA is based on…

BySenior EditorApril 20, 2021

PharmaShots Interview: Janssen’s Dr. Allitia DiBernardo Shares Insights on the Availability of Ponvory in the US

PharmaShots Interview: Biogen’s Monica Mann Shares Insight on Plegridy to Treat Multiple Sclerosis

Contact US

OUR INFORMATION

FOLLOW US